McClellan WM[au] - Search Results

Year	Number of Results
1973	1
1980	1
1984	1
1985	1
1988	1
1991	1
1992	1
1993	1
1994	1
1995	2
1996	3
1997	4
1998	3
1999	5
2000	6
2001	4
2002	11
2003	11
2004	7
2005	11
2006	13
2007	2
2008	7
2009	10
2010	11
2011	7
2012	15
2013	12
2014	9
2015	7
2016	7
2017	5
2018	3
2022	0

1

Epidemiology, geography and chronic kidney disease.

McClellan AC, Plantinga L, McClellan WM. McClellan AC, et al. Among authors: mcclellan wm. Curr Opin Nephrol Hypertens. 2012 May;21(3):323-8. doi: 10.1097/MNH.0b013e3283521dae. Curr Opin Nephrol Hypertens. 2012. PMID: 22388555 Review.

2

A public health perspective on CKD and obesity.

McClellan WM, Plantinga LC. McClellan WM, et al. Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv37-42. doi: 10.1093/ndt/gft030. Nephrol Dial Transplant. 2013. PMID: 24179014 Review.

3

Anemia and cardiovascular and kidney disease.

Jurkovitz C, Abramson J, McClellan WM. Jurkovitz C, et al. Among authors: mcclellan wm. Curr Opin Nephrol Hypertens. 2006 Mar;15(2):117-22. doi: 10.1097/01.mnh.0000214769.11609.2d. Curr Opin Nephrol Hypertens. 2006. PMID: 16481876 Review.

4

Influence of race, ethnicity and socioeconomic status on kidney disease.

Patzer RE, McClellan WM. Patzer RE, et al. Among authors: mcclellan wm. Nat Rev Nephrol. 2012 Sep;8(9):533-41. doi: 10.1038/nrneph.2012.117. Epub 2012 Jun 26. Nat Rev Nephrol. 2012. PMID: 22735764 Free PMC article. Review.

5

ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology.

McClellan WM, Plantinga LC, Wilk AS, Patzer RE. McClellan WM, et al. Clin J Am Soc Nephrol. 2017 Jan 6;12(1):210-216. doi: 10.2215/CJN.02370316. Epub 2016 Nov 16. Clin J Am Soc Nephrol. 2017. PMID: 27852663 Free PMC article. Review.

6

Poverty and mortality in hemodialysis patients.

McClellan WM, McClellan CB. McClellan WM, et al. J Am Soc Nephrol. 2013 Feb;24(2):165-7. doi: 10.1681/ASN.2012121176. Epub 2013 Jan 18. J Am Soc Nephrol. 2013. PMID: 23334391 Free article. No abstract available.

7

Screening for chronic kidney disease: unresolved issues.

McClellan WM, Ramirez SP, Jurkovitz C. McClellan WM, et al. J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S81-7. doi: 10.1097/01.asn.0000070144.86024.04. J Am Soc Nephrol. 2003. PMID: 12819308 Free article. Review.

8

Achieving the goal: results from the Fistula First Breakthrough Initiative.

Lynch JR, Mohan S, McClellan WM. Lynch JR, et al. Among authors: mcclellan wm. Curr Opin Nephrol Hypertens. 2011 Nov;20(6):583-92. doi: 10.1097/MNH.0b013e32834b33c4. Curr Opin Nephrol Hypertens. 2011. PMID: 21897231 Review.

9

Epidemiology and risk factors for chronic kidney disease.

McClellan WM. McClellan WM. Med Clin North Am. 2005 May;89(3):419-45. doi: 10.1016/j.mcna.2004.11.006. Med Clin North Am. 2005. PMID: 15755460 Review.

10

Risk factors for progressive chronic kidney disease.

McClellan WM, Flanders WD. McClellan WM, et al. J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S65-70. doi: 10.1097/01.asn.0000070147.10399.9e. J Am Soc Nephrol. 2003. PMID: 12819305 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results